Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Igor S Chernov"'
Autor:
Irina V Kolyadina, Irina S Bulavina, Vladislav V Petkau, Natalia V Strakhova, Vera A Gorbunova, Elena I Kovalenko, Liudmila V Manziuk, Elena V Artamonova, Liudmila G Zhukova, Larisa V Bolotina, Inna P Gan'shina, Tatiana Iu Semiglazova, Aleksei G Manikhas, Natalia A Raevskaia, Ilia M Itkin, Svetlana V Khokhlova, Dmitrii V Filonenko, Viktor E Gol'dberg, Natalia O Popova, Dmitrii M Ponomarenko, Valentina E Shikina, Liubov I Vladimirova, Natalia M Tikhanovskaia, Elena V Karabina, Guzel Z Mukhametshina, Alfiia I Khasanova, Sufiia Z Safina, Mikhail V Shaidorov, Andrei E Orlov, Iuliia V Kostalanova, Natalia V Levchenko, Mikhail A Osipov, Tatiana V Karandeeva, Irina V Evstigneeva, Igor S Chernov, Dzheims Dzh Kolokolov, Anton Iu Povyshev, Alina S Shatokhina, Elena M Cherniakova, Oksana N Shkodenko, Evgeniia S Kuz'mina
Publikováno v:
Современная онкология, Vol 21, Iss 2, Pp 17-24 (2019)
Aim. Eribulin is an active cytostatic, associated with a wide range of mechanisms of antitumor effects, but eribulin efficiency and safety in patients with breast cancer (BC), associated with cerebral metastases are still poorly understood. Materials
Externí odkaz:
https://doaj.org/article/5f21fe71ca7c49f6a857b2579dfadccd
Autor:
Vera A Gorbunova, Irina V Kolyadina, Elena I Kovalenko, Liudmila V Manziuk, Elena V Artamonova, Liudmila G Zhukova, Larisa V Bolotina, Tat'iana Iu Semiglazova, Aleksei G Manikhas, Natal'ia A Raevskaia, Il'ia M Itkin, Dmitrii V Filonenko, Larisa A Zhilyaeva, Viktor E Gol'dberg, Natal'ia O Popova, Dmitrii M Ponomarenko, Valentina E Shikina, Irina R Suslova, Olga V Romanchuk, Dmitrii V Kozlov, Ali-Dzarakhmat S Rzaev, Vasilii V Marfutov, Irina I Andreiashkina, Liubov' I Vladimirova, Irina S Mitashok, Natal'ia M Tikhanovskaia, Elena V Karabina, Guzel' Z Mukhametshina, Al'fiia I Khasanova, Sufiia Z Safina, Mikhail V Shaidorov, Dmitrii A Morozov, Elena P Prokof'eva, Liudmila V Kramskaia, Tat'iana V Karandeeva, Irina V Evstigneeva, Elena G Ovchinnikova, Tat'iana P Klement'eva, Olga V Khrupalo, Elena V Tiuvinova, Viktor M Sherstnev, Igor' S Chernov, Dzheims Dzh Kolokolov, Elena A Gaisina, Natal'ia V Levchenko, Viacheslav A Chubenko, Anton Iu Povyshev, Inna V Iudina, Liudmila V Vorotilina, Tat'iana V Andreeva, Garnik S Tumanian, Anton E Koziakov, Liudmila A Gil'mutdinova, Mikhail A Osipov, Alina S Shatokhina, Alena A Vazhenina, Angelina S Chichkanova, Vladimir I Vladimirov, Aleksandr N Ivanov, Anna S Belokhvostova, Elena M Cherniakova, Elena A Tul'china, Svetlana A Maklashova, Oksana N Shkodenko, Iuliia V Kostalanova, Anna V Tarasova, Evgeniia S Kuz'mina
Publikováno v:
Современная онкология, Vol 21, Iss 1, Pp 12-23 (2019)
Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice. Materials and methods. The analysis included 459 patients with advanced BC from 44 federal and mu
Externí odkaz:
https://doaj.org/article/fab8f79eb72a4ebeb4af3ca5e29be2e9
Autor:
Natal'ia M Tikhanovskaia, Elena Karabina, Igor' S Chernov, Tat'iana V Karandeeva, Mikhail A Osipov, Irina V. Kolyadina, Ali-Dzarakhmat S Rzaev, Dmitrii V. Kozlov, Sufiia Z Safina, Vasilii V. Marfutov, Elena P Prokof'eva, Oksana N Shkodenko, Alena A Vazhenina, Tat'iana V Andreeva, Elena G. Ovchinnikova, Irina R. Suslova, Elena I. Kovalenko, Olga V Khrupalo, Tat'iana Iu Semiglazova, Liudmila V. Vorotilina, Irina I. Andreiashkina, Elena V. Artamonova, Anton Iu Povyshev, Angelina S Chichkanova, Olga V Romanchuk, Vera A Gorbunova, Liubov' I Vladimirova, Elena A. Gaisina, Garnik S Tumanian, Iuliia V Kostalanova, Liudmila A Gil'mutdinova, Irina S Mitashok, Liudmila V Manziuk, Dmitrii M Ponomarenko, Evgeniia S Kuz'mina, Al'fiia I Khasanova, Guzel' Z Mukhametshina, Vladimir I. Vladimirov, Dmitrii A Morozov, Liudmila V. Kramskaia, Mikhail V Shaidorov, V E Goldberg, Inna V Iudina, Valentina E Shikina, Liudmila G. Zhukova, N. O. Popova, Irina V. Evstigneeva, Anton E. Koziakov, Elena A Tul'china, Elena V Tiuvinova, Il'ia M Itkin, Alina S Shatokhina, Aleksei G Manikhas, Dzheims Dzh Kolokolov, Anna S Belokhvostova, Natal'ia V Levchenko, Svetlana A Maklashova, Aleksandr N Ivanov, Larisa Bolotina, Anna V Tarasova, Dmitrii V Filonenko, Viacheslav A. Chubenko, Natal'ia A Raevskaia, Viktor M Sherstnev, Elena M Cherniakova, Tat'iana P Klement'eva, Larisa A Zhilyaeva
Publikováno v:
Современная онкология, Vol 21, Iss 1, Pp 12-23 (2019)
Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice. Materials and methods. The analysis included 459 patients with advanced BC from 44 federal and mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a6a2dd4170f83bf2d09813743b639af
https://doi.org/10.26442/18151434.2019.1.190250
https://doi.org/10.26442/18151434.2019.1.190250